Mawson Dips on Revealing Presentation
Mawson Infrastructure Group Inc. (NASDAQ: MIGI) shares moved lower Monday, as the Midland, Pa.-based publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high-performance computing (HPC), and digital assets, today released its updated Company Presentation. Key Highlights from the 2025 Company Presentation:• 136% year-over-year revenue growth (FY2024 vs FY2023) in digital colocation business.• 36% year-over-year revenue growth in total revenue with an increasingly optimized revenue mix across digital colocation, energy management, and digital assets mining while also building towards artificial intelligence (AI) and high-performance computing (HPC) offerings, along with positive cash flows from operations.• Expanded digital colocation business with platform growing to becoming a multi-tenant platform across several enterprise-grade institutional customers during 2024, becoming one of the largest digital colocation businesses amongst itsJun publicly-traded peers.• Signed AI/HPC colocation business agreement with AI customer for deployment of NVIDIA GPUs for initial 20 MW deployment with an additional LOI for potential expansion to 144 MW.• Mawson also boasted a 31% year-over-year increase in operating hash rate and optimization of infrastructure to 4.98 EH/s (exahashes per second).• Expansion funded entirely through cash from operations and enhanced operational and management capabilities.• Increased operational capacity to 129 MW with further planned expansion to 153 MW upon Ohio facility completion.• MIGI shares fell two cents, or 2.5%, to 84 cents.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


